Company news
Crinetics Pharmaceuticals, Inc. news in 2023
Crinetics Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome
December 17, 2023
Crinetics Pharmaceuticals Announces December 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 10, 2023
Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences
November 19, 2023
Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 9, 2023
Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 6, 2023
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 9, 2023
Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
September 19, 2023
Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly
September 9, 2023
Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 7, 2023
Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly
July 30, 2023
New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023
June 20, 2023
Crinetics to Highlight Broad Pipeline at ENDO 2023
June 8, 2023
Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 3, 2023
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
February 27, 2023
Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
February 9, 2023
Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference
January 8, 2023
Decks in 2023
- Technical Presentation (December 2023)
Technical · 20 slides · Dec 18, 2023
- Technical Presentation (September 2023)
Technical · 24 slides · Sep 11, 2023
- Investor Presentation (January 2023)
Investor deck · 36 slides · Jan 9, 2023